根据向美国证券交易委员会（SEC）提交的文件显示，生物制药公司Outlook Therapeutics, Inc.已与投资银行H.C. Wainwright & Co.签订了一项市场股票发行（At-The-Market, ATM）协议。
根据该协议条款，Outlook Therapeutics将有权在特定时期内，通过H.C. Wainwright作为销售代理，不定期地发行和出售其普通股股票，以此筹集资金。此次ATM发行的总融资额度最高可达1亿美元。
市场股票发行（ATM）是一种灵活的融资工具，允许上市公司根据市场条件和自身资金需求，在既定额度内按现行市价向公众投资者出售新发行的股票。这种安排为公司提供了高效的资金获取渠道，同时能够减少对股价可能造成的单次重大冲击。
此次融资所得，预计将用于推进公司管线产品的研发、临床试验以及一般企业用途，为其核心业务的发展提供资金支持。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.